Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion
- Posted on December 16, 2025
- By South China Morning Post
- 3 Views
Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion
Yarrow Bioscience gets exclusive global rights for the GenSci098 therapy to treat thyroid eye disease and Graves’ disease.
